These effects were linked to miR-27b-3p, a target of CHROMR that is significantly reduced in DLBCL and controls expression of pro-tumorigenic mesenchymal-epithelial transition factor (MET). Here, CHROMR is linked to diffuse large B-cell lymphoma.